China · Delayed Price · Currency is CNY Revance Therapeutics Statistics
Total Valuation
SHA:605090 has a market cap or net worth of CNY 18.34 billion. The enterprise value is 16.05 billion.
| Market Cap | 18.34B |
| Enterprise Value | 16.05B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Jun 3, 2025 |
Share Statistics
SHA:605090 has 654.11 million shares outstanding. The number of shares has increased by 1.61% in one year.
| Current Share Class | 654.11M |
| Shares Outstanding | 654.11M |
| Shares Change (YoY) | +1.61% |
| Shares Change (QoQ) | +3.26% |
| Owned by Insiders (%) | 22.24% |
| Owned by Institutions (%) | 8.08% |
| Float | 255.94M |
Valuation Ratios
The trailing PE ratio is 11.21 and the forward PE ratio is 10.36.
| PE Ratio | 11.21 |
| Forward PE | 10.36 |
| PS Ratio | 0.87 |
| PB Ratio | 1.80 |
| P/TBV Ratio | 2.15 |
| P/FCF Ratio | 56.41 |
| P/OCF Ratio | 9.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.36, with an EV/FCF ratio of 49.37.
| EV / Earnings | 9.39 |
| EV / Sales | 0.76 |
| EV / EBITDA | 10.36 |
| EV / EBIT | 10.44 |
| EV / FCF | 49.37 |
Financial Position
The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.91 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 10.11 |
| Interest Coverage | 12.26 |
Financial Efficiency
Return on equity (ROE) is 18.01% and return on invested capital (ROIC) is 7.25%.
| Return on Equity (ROE) | 18.01% |
| Return on Assets (ROA) | 6.39% |
| Return on Invested Capital (ROIC) | 7.25% |
| Return on Capital Employed (ROCE) | 12.18% |
| Revenue Per Employee | 11.84M |
| Profits Per Employee | 955,081 |
| Employee Count | 1,790 |
| Asset Turnover | 1.41 |
| Inventory Turnover | 39.28 |
Taxes
In the past 12 months, SHA:605090 has paid 207.97 million in taxes.
| Income Tax | 207.97M |
| Effective Tax Rate | 10.86% |
Stock Price Statistics
The stock price has decreased by -4.74% in the last 52 weeks. The beta is 0.35, so SHA:605090's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -4.74% |
| 50-Day Moving Average | 26.75 |
| 200-Day Moving Average | 26.71 |
| Relative Strength Index (RSI) | 48.18 |
| Average Volume (20 Days) | 4,973,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605090 had revenue of CNY 21.20 billion and earned 1.71 billion in profits. Earnings per share was 2.50.
| Revenue | 21.20B |
| Gross Profit | 2.09B |
| Operating Income | 1.54B |
| Pretax Income | 1.92B |
| Net Income | 1.71B |
| EBITDA | n/a |
| EBIT | 1.54B |
| Earnings Per Share (EPS) | 2.50 |
Balance Sheet
The company has 5.93 billion in cash and 3.29 billion in debt, giving a net cash position of 2.65 billion or 4.04 per share.
| Cash & Cash Equivalents | 5.93B |
| Total Debt | 3.29B |
| Net Cash | 2.65B |
| Net Cash Per Share | 4.04 |
| Equity (Book Value) | 10.21B |
| Book Value Per Share | 15.46 |
| Working Capital | 4.84B |
Cash Flow
In the last 12 months, operating cash flow was 1.86 billion and capital expenditures -1.53 billion, giving a free cash flow of 325.17 million.
| Operating Cash Flow | 1.86B |
| Capital Expenditures | -1.53B |
| Free Cash Flow | 325.17M |
| FCF Per Share | 0.50 |
Margins
Gross margin is 9.86%, with operating and profit margins of 7.26% and 8.06%.
| Gross Margin | 9.86% |
| Operating Margin | 7.26% |
| Pretax Margin | 9.04% |
| Profit Margin | 8.06% |
| EBITDA Margin | n/a |
| EBIT Margin | 7.26% |
| FCF Margin | 1.53% |
Dividends & Yields
This stock pays an annual dividend of 1.23, which amounts to a dividend yield of 4.57%.
| Dividend Per Share | 1.23 |
| Dividend Yield | 4.57% |
| Dividend Growth (YoY) | 75.53% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 32.77% |
| Buyback Yield | -1.61% |
| Shareholder Yield | 2.84% |
| Earnings Yield | 9.32% |
| FCF Yield | 1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 1.4.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHA:605090 has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.7 |
| Piotroski F-Score | 7 |